Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. Suffolk
    4. ›
  4. 11722
    5. ›
  5. CVD EQUIPMENT CORPORATION

CVD EQUIPMENT CORPORATION

Headquarter
Company claim

Is this your business?

Get access!

Company Details

Name: CVD EQUIPMENT CORPORATION
Jurisdiction: New York
Legal type: DOMESTIC BUSINESS CORPORATION
Status: Active
Date of registration: 13 Oct 1982 (43 years ago)
Entity Number: 797953
ZIP code: 11722
County: Suffolk
Place of Formation: New York
Address: 355 SOUTH TECHNOLOGY DRIVE, CENTRAL ISLIP, NY, United States, 11722

Shares Details

Shares issued 200

Share Par Value 0

Type NO PAR VALUE

DOS Process Agent

Name Role Address
RICHARD CATALANO DOS Process Agent 355 SOUTH TECHNOLOGY DRIVE, CENTRAL ISLIP, NY, United States, 11722

Chief Executive Officer

Name Role Address
EMMANUEL LAKIOS Chief Executive Officer 355 SOUTH TECHNOLOGY DRIVE, CENTRAL ISLIP, NY, United States, 11722

Links between entities

Type:
Headquarter of
Company Number:
000-518-227
State:
Alabama
Alabama profile:
CVD EQUIPMENT CORPORATION (AL)
Type:
Headquarter of
Company Number:
01db26b6-a0d4-e011-a886-001ec94ffe7f
State:
MINNESOTA
MINNESOTA profile:
CVD EQUIPMENT CORPORATION (MN)
Type:
Headquarter of
Company Number:
F17000001631
State:
FLORIDA
FLORIDA profile:
CVD EQUIPMENT CORPORATION (FL)

U.S. Small Business Administration Profile

Website:
www.stainlessdesign.com
Phone Number:
845-246-3631
E-mail Address:
dscarpinati@stainlessdesign.com
Contact Person:
DEBRA SCARPINATI
User ID:
P2440214
Website:
HTTP://WWW.CVDEQUIPMENT.COM
Phone Number:
631-981-7081
E-mail Address:
Elakios@cvdequipment.com
Fax Number:
631-981-7095
Contact Person:
EMMANUEL LAKIOS
User ID:
P0128164

Unique Entity ID

Unique Entity ID:
PHV4F6NMWQQ4
CAGE Code:
8W867
UEI Expiration Date:
2025-11-25

Business Information

URL:
HTTP://WWW.CVDEQUIPMENT.COM
Division Name:
CVD EQUIPMENT CORPORATION
Division Number:
01
Activation Date:
2024-11-26
Initial Registration Date:
2001-05-21

Central Index Key

CIK number:
0000766792
Phone:
6319817081
EDGAR Link:
View company profile on EDGAR website

Latest Filings

Form type:
SCHEDULE 13G/A
File number:
005-40349
Filing date:
2025-06-24
File:
View File
Form type:
DEF 14A
File number:
001-16525
Filing date:
2025-06-20
File:
View File
Form type:
SD
File number:
001-16525
Filing date:
2025-05-30
File:
View File
Form type:
SCHEDULE 13G/A
File number:
005-40349
Filing date:
2025-05-14
File:
View File
Form type:
10-Q
File number:
001-16525
Filing date:
2025-05-13
File:
View File

Commercial and government entity program

CAGE number:
8W867
Status:
Active
Type:
U.S./Canada Manufacturer
CAGE Update Date:
2024-11-26
CAGE Expiration:
2029-11-26
SAM Expiration:
2025-11-25

Contact Information

POC:
EMMANUEL LAKIOS
Corporate URL:
http://www.cvdequipment.com

History

Start date End date Type Value
2024-12-17 2024-12-17 Address 355 SOUTH TECHNOLOGY DRIVE, CENTRAL ISLIP, NY, 11722, USA (Type of address: Chief Executive Officer)
2022-01-20 2024-12-17 Shares Share type: PAR VALUE, Number of shares: 20000000, Par value: 0.01
2020-10-19 2024-12-17 Address 355 SOUTH TECHNOLOGY DRIVE, CENTRAL ISLIP, NY, 11722, USA (Type of address: Service of Process)
2016-12-15 2022-01-20 Shares Share type: PAR VALUE, Number of shares: 20000000, Par value: 0.01
2016-10-03 2020-10-19 Address 355 SOUTH TECHNOLOGY DRIVE, CENTRAL ISLIP, NY, 11722, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
241217002080 2024-12-17 BIENNIAL STATEMENT 2024-12-17
201019060143 2020-10-19 BIENNIAL STATEMENT 2020-10-01
190510060110 2019-05-10 BIENNIAL STATEMENT 2018-10-01
161215000237 2016-12-15 CERTIFICATE OF AMENDMENT 2016-12-15
161003008201 2016-10-03 BIENNIAL STATEMENT 2016-10-01

USAspending Awards / Contracts

Procurement Instrument Identifier:
N0017324P0942
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
PURCHASE ORDER
Action Obligation:
14385.00
Base And Exercised Options Value:
14385.00
Base And All Options Value:
14385.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2024-07-18
Description:
SPARE PARTS: ASSEMBLY, RECONDITIONED, SBC, BL1730, PROGRAMMED, C-1500 HGC EQUIPMENT SERVICES: LABOR AND EXPENSES TO PROVIDE UP TO 8 HOURS OF ONSITE EQUIPMENT SERVICE
Naics Code:
334516: ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Product Or Service Code:
J066: MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT
Procurement Instrument Identifier:
N0017323PX004
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
PURCHASE ORDER
Action Obligation:
67510.00
Base And Exercised Options Value:
67510.00
Base And All Options Value:
67510.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2023-09-27
Description:
THIS MODIFICATION ADDS QUOTE # 10339F AS ATTACHMENT 2, INCLUDES LANGUAGE ADDING THE QUOTE TO THE SPECIFICATION, AND INCREASES THE AGREEMENT COST BY $67,510.
Naics Code:
333994: INDUSTRIAL PROCESS FURNACE AND OVEN MANUFACTURING
Product Or Service Code:
6640: LABORATORY EQUIPMENT AND SUPPLIES
Procurement Instrument Identifier:
N0017323P0918
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
PURCHASE ORDER
Action Obligation:
24580.00
Base And Exercised Options Value:
24580.00
Base And All Options Value:
24580.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2023-09-26
Description:
FIELD SERVICE
Naics Code:
333994: INDUSTRIAL PROCESS FURNACE AND OVEN MANUFACTURING
Product Or Service Code:
4430: INDUSTRIAL FURNACES, KILNS, LEHRS, AND OVENS

USAspending Awards / Financial Assistance

Date:
2022-09-13
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
FLUID CHANNEL ARRAY BRICK (FAB) BLOOD-GAS EXCHANGERS FOR BUILDING ARTIFICIAL LUNGS FOR CRITICAL RESPIRATORY FAILURE TREATMENT - PROJECT SUMMARY/ABSTRACT ESSENTIAL LIFE-MAINTAINING O2 AND CO2 GAS EXCHANGE FOR OVER 1 MILLION PATIENTS WORLDWIDE WITH CRITICAL RESPIRATORY FAILURE OR UNDERGOING HEART/LUNG SURGERY IS PROVIDED BY FLOWING BLOOD THROUGH AN EXTRACORPOREAL CIRCUIT CONTAINING AN OXYGENATOR. COMMERCIALLY AVAILABLE OXYGENATORS USE PROPRIETARY SPACED ASSEMBLIES OF HOLLOW FIBERS (HFS) AS BLOOD-GAS EXCHANGERS. BLOOD FLOWS TURBULENTLY AROUND THE OUTSIDE OF THESE HFS WHILE A SWEEP GAS FLOWS THROUGH THEIR HOLLOW CHANNELS. THROUGH THE MICROPOROUS HF WALLS, O2 DIFFUSES INTO THE BLOOD, AND CO2 DIFFUSES OUT, CONVERTING VENOUS BLOOD INTO ARTERIAL BLOOD. KEY HEMOSTATIC COMPLICATION RISK FACTORS OF OXYGENATORS, LIKE BLOOD-CONTACT AREA, PRIMING VOLUME, TURBULENT AND HIGH-PRESSURE FLOW CONDITIONS, ACCUMULATED SHEAR STRESS, AND GAS TRANSFER RATE DECAY POSE CONTINUOUS HEALTH RISKS THAT AFFECT COSTS, TREATMENT, AND RECOVERY, AND FURTHER AGGRAVATED BY PROLONGED USE, CONTRIBUTE SIGNIFICANTLY TO MORBIDITY AND MORTALITY. HF OXYGENATOR TECHNOLOGY HAS ONLY INCREMENTALLY IMPROVED OVER THE LAST DECADE AND ALTERNATIVE TECHNOLOGIES THAT COULD SIGNIFICANTLY IMPROVE PERFORMANCE AND/OR SAFETY ARE STILL IN THEIR LOW FLOW CAPACITY STAGE. THE GOAL OF THIS SBIR PROPOSAL IS TO DEVELOP OPTIMIZED NOVEL FLUID CHANNEL ARRAY BRICK (FAB) BLOOD-GAS EXCHANGERS, FOR MAXIMIZING SAFETY GAINS AND USE TIME FOR AN OPTIMIZED FAMILY OF SAFER FAB-OXYGENATORS. FABS HAVE A PATTERNED ARRAY OF STRAIGHT FLUID CHANNELS WITH LAMINAR BLOOD FLOW PATHS, HIGHER POROSITY FOR GAS EXCHANGE, AND A HIGHER SURFACE-AREA-TO-VOLUME RATIO COMPARED TO AN EQUIVALENT HF ASSEMBLY. OPTIMIZED HIGHER EFFICIENCY FABS WILL LEAD TO SIGNIFICANT EXTRACORPOREAL OXYGENATOR SAFETY GAINS. THIS WILL DECREASE BLOOD DAMAGE AND COAGULATION RISK, UNLOCK LONGER USAGE POTENTIAL, REDUCE BLOOD PRODUCT TRANSFUSIONS, AND REPLACEMENT FREQUENCY DURING LONG-TERM USE, WHICH FURTHER REDUCES HEALTHCARE COSTS AND INFECTION RISKS. THE LONG-TERM GOAL OF THE SBIR PROPOSAL IS TO ENABLE THE DEVELOPMENT OF A FAMILY OF SAFER FAB-OXYGENATORS, WITH EACH DEVICE TAILORED TO THE NEEDS OF A SPECIFIC PATIENT CLASS. FAB-OXYGENATOR SCALE-UP TO ADULT PATIENT CLASS, TOGETHER WITH FULLY OPTIMIZED FABS, UNDER A FUTURE DEVELOPMENT, COULD LEAD TO AN EXTRACORPOREAL ARTIFICIAL LUNG. IN PHASE I, WE WILL DESIGN/MANUFACTURE A SERIES OF FABS WITH DIFFERENT FLUID CHANNEL ARRAY PATTERNS AND TEST THEM INSIDE FAB-OXYGENATORS FOR UP TO 6 HOURS. THESE RESULTS WILL BE USED TO DEVELOP A PERFORMANCE PREDICTION FOR AN OPTIMIZED, FULL ADULT FAB-OXYGENATORS INCORPORATING RESPECTIVE OPTIMIZED FABS. FEASIBILITY WILL BE ESTABLISHED BY IN VITRO EVALUATION UNDER THE FDA-RECOMMENDED AAMI 7199 TEST PROTOCOL OF OPTIMIZED FABS, MODELING, AND ADULT FAB-OXYGENATOR DESIGN PERFORMANCE PREDICTION COMPARISON TO COMMERCIALLY HF OXYGENATORS. PHASE II FUNDING WILL ALLOW TO DEVELOP AND TEST FURTHER IMPROVED AND/OR ANTITHROMBOTIC COATED FABS FOR UP TO 7 DAYS OF USE, AND TO CONDUCT FIRST IN VIVO TESTING TO REFINE SAFETY GAIN ADVANTAGES. WE PLAN TO ESTABLISH LICENSING AND FAB-SUPPLY PARTNERSHIPS WITH OXYGENATOR MANUFACTURERS AND TO ASSEMBLE A TEAM OF EXPERTS, CLINICIANS, MARKETERS, MANUFACTURERS, AND ENGINEERS WHO CAN JOINTLY BRING FAB-OXYGENATORS TO MARKET.
Obligated Amount:
183278.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2022-05-27
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
DEVELOPMENT OF HIGHER EFFICIENCY AND SAFER OXYGENATORS FOR CRITICAL RESPIRATORY FAILURE TREATMENT AND HEART/LUNG SURGERY ASSIST - PROJECT SUMMARY/ABSTRACT ESSENTIAL LIFE-MAINTAINING O2 AND CO2 GAS EXCHANGES FOR OVER 700,000 PATIENTS WORLDWIDE WITH CRITICAL RESPIRATORY FAILURE OR UNDERGOING HEART/LUNG SURGERY ARE PROVIDED BY FLOWING BLOOD THROUGH AN CIRCUIT CONTAINING AN EXTRACORPOREAL OXYGENATOR. COMMERCIALLY AVAILABLE OXYGENATORS USE HOLLOW FIBERS (HF) AS GAS EXCHANGE COMPONENTS. BLOOD FLOWS TURBULENTLY AROUND THE OUTSIDE OF THESE HFS WHILE A SWEEP GAS FLOWS THROUGH THEIR HOLLOW CHANNELS. THROUGH THE MICROPOROUS HF WALLS, O2 DIFFUSES INTO THE BLOOD, AND CO2 DIFFUSES OUT, CONVERTING VENOUS BLOOD INTO ARTERIAL BLOOD. HOWEVER, KEY HEMOSTATIC COMPLICATION RISK FACTORS, LIKE BLOOD- CONTACT AREA, PRIMING VOLUME, TURBULENT AND HIGH-PRESSURE FLOW CONDITIONS, AND ACCUMULATED SHEAR STRESS, POSE CONTINUOUS HEALTH RISKS THAT AFFECT TREATMENT AND RECOVERY (I.E., TEMPORARY COGNITIVE IMPAIRMENT, ETC.) AND CONTRIBUTE TO SIGNIFICANT MORBIDITY AND MORTALITY (I.E., MULTIPLE ORGAN FAILURES, ETC.), WHICH ARE FURTHER AGGRAVATED WITH PROLONGED USE. HF OXYGENATOR TECHNOLOGY HAS ONLY INCREMENTALLY IMPROVED OVER THE LAST DECADE AND ALTERNATIVE TECHNOLOGIES THAT COULD SIGNIFICANTLY IMPROVE PERFORMANCE AND/OR SAFETY ARE STILL IN THEIR INFANT (LOW FLOW CAPACITY) STAGE. THE GOAL OF THIS SBIR PROPOSAL IS TO DEVELOP FIRST A PEDIATRIC AND THEN AN ADULT SAFER FAB- OXYGENATOR. FAB-OXYGENATORS INCORPORATE NOVEL GAS EXCHANGE COMPONENTS (FLUID CHANNEL ARRAY BRICKS, HEREIN CALLED “FABS”) HAVING A STRAIGHT AND LAMINAR BLOOD FLOW PATH, LOW-PRESSURE DROP, AND A HIGHER O2 AND CO2 GAS TRANSFER EFFICIENCY. THESE FAB-OXYGENATORS PROVIDE THE REQUIRED O2 AND CO2 GAS TRANSFER RATES WITH LOWER LEVELS OF MULTIPLE KEY HEMOSTATIC COMPLICATION RISK FACTORS, I.E. (I) BLOOD CONTACT SURFACE AREA, (II) PRIMING VOLUME, (III) PRESSURE DROP, AND (IV) ACCUMULATED STRESS, THEREBY IMPROVING PATIENT SAFETY. THESE RISK FACTORS AFFECT BLOOD DAMAGE AND LOSS, PLATELET ACTIVATION, COAGULATION RISK, DEMAND FOR BLOOD PRODUCTS, AND GAS TRANSFER RATE STABILITY. THE LONG-TERM GOAL OF THIS SBIR PROPOSAL IS TO DEVELOP A FAMILY OF SAFER OXYGENATORS, OPTIMALLY CONFIGURED FOR EACH PATIENT CLASS (NEONATAL, PEDIATRIC, SMALL, AND LARGE ADULTS). FAB-OXYGENATOR SCALE-UP TO ADULT PATIENT CLASS, TOGETHER WITH FULLY OPTIMIZED FABS, UNDER A FUTURE DEVELOPMENT, COULD LEAD TO AN EXTRACORPOREAL ARTIFICIAL LUNG. IN PHASE I, WE WILL DEVELOP A SAFER PEDIATRIC FAB-OXYGENATOR. FEASIBILITY WILL BE ESTABLISHED BY COMPARISON TO COMMERCIALLY AVAILABLE PEDIATRIC HF OXYGENATORS THROUGH IN VITRO EVALUATION UNDER THE FDA-RECOMMENDED AAMI 7199 TEST PROTOCOL, AND WITH MODELING AND A SAFETY MERIT FUNCTION VALUE COMPARISON. PHASE II, IF GRANTED, WILL BE SUFFICIENT TO COMPLETE EXTENDED IN VITRO VERIFICATION/VALIDATION OF UP TO ADULT SIZE FAB-OXYGENATORS, PERFORM THE FIRST IN VIVO TESTS, BEGIN THE TRANSFER TO VOLUME MANUFACTURING, AND PREPARE FOR FDA SUBMISSION. WE PLAN TO ESTABLISH FAB-OXYGENATOR DESIGN LICENSING/TECHNOLOGY TRANSFER AND FABS/FAB-SUBASSEMBLY SUPPLY PARTNERSHIPS WITH MULTIPLE OXYGENATOR MANUFACTURERS AND TO ASSEMBLE A TEAM OF EXPERTS, CLINICIANS, MARKETERS, MANUFACTURERS, AND ENGINEERS WHO CAN JOINTLY BRING FAB-OXYGENATORS INTO THE MARKET.
Obligated Amount:
193590.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2020-04-16
Link:
View on USAspending
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
2415970.00
Total Face Value Of Loan:
2415970.00
Date:
2020-04-16
Link:
View on USAspending
Awarding Agency Name:
Small Business Administration
Transaction Description:
TO AID SMALL BUSINESSES IN MAINTAINING WORK FORCE DURING COVID-19 PANDEMIC.
Obligated Amount:
0.00
Face Value Of Loan:
2415970.00
Total Face Value Of Loan:
2415970.00

Trademarks Section

Serial Number:
88687115
Mark:
FIRSTNANO
Status:
Registered. The registration date is used to determine when post-registration maintenance documents are due.
Mark Type:
Trademark, Service Mark
Application Filing Date:
2019-11-11
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
FIRSTNANO
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Manufacturing machinery, namely, chemical vapor deposition machines for use in manufacturing in the nanotechnology, solar, energy, microelectromechanical systems, and semiconductor industries
First Use:
2005-05-13
International Classes:
007 - Primary Class
Class Status:
ACTIVE
For:
Technology consultation in the field of material processes
First Use:
2005-05-13
International Classes:
042 - Primary Class
Class Status:
ACTIVE
Serial Number:
86229650
Mark:
SDC
Status:
The registration has been renewed.
Mark Type:
Trademark
Application Filing Date:
2014-03-24
Mark Drawing Type:
4 - STANDARD CHARACTER MARK
Mark Literal Elements:
SDC
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Chemical and gas delivery systems for laboratory and industrial use comprising storage tanks, valves, lines in the nature of hoses and pipes, diverters and controllers for storing and dispensing chemicals and gases
First Use:
1998-12-31
International Classes:
007 - Primary Class
Class Status:
ACTIVE
Serial Number:
73464433
Mark:
CVD
Status:
Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Trademark
Application Filing Date:
1984-02-06
Mark Drawing Type:
1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Literal Elements:
CVD
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Gas Flow Controls, Gas Pressure Regulators, and Microprocessors
First Use:
1983-05-26
International Classes:
009 - Primary Class
Class Status:
SECTION 8 - CANCELLED
For:
Hydrogen Gas Purification Systems Comprising Filters, Hydrogen Annealing Furnaces and Industrial Reactors for Metallorganic Chemical Vapor Deposition
First Use:
1983-09-12
International Classes:
011 - Primary Class
Class Status:
SECTION 8 - CANCELLED
For:
Cabinets for Gas Cylinder Storage
First Use:
1983-08-19
International Classes:
020 - Primary Class
Class Status:
SECTION 8 - CANCELLED
Serial Number:
86648732
Mark:
N FIRST NANO
Status:
A Sections 8 and 15 combined declaration has been accepted and acknowledged.
Mark Type:
Trademark, Service Mark
Application Filing Date:
2015-06-02
Mark Drawing Type:
5 - AN ILLUSTRATION DRAWING WITH WORD(S)/LETTER(S)/NUMBER(S) IN STYLIZED FORM
Mark Literal Elements:
N FIRST NANO
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Manufacturing machinery, namely, chemical vapor deposition machines for use in manufacturing in the nanotechnology, solar, energy, microelectromechanical systems, and semiconductor industries
First Use:
2005-05-13
International Classes:
007 - Primary Class
Class Status:
ACTIVE
For:
Technology consultation in the field of material processes
First Use:
2005-05-13
International Classes:
042 - Primary Class
Class Status:
ACTIVE
Serial Number:
76388149
Mark:
EASYTUBE
Status:
The registration has been renewed.
Mark Type:
Trademark
Application Filing Date:
2002-03-28
Mark Drawing Type:
1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Literal Elements:
EASYTUBE
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
MACHINE FOR FABRICATION OF CARBON NANOTUBES AND NANOTUBES DEVICES
First Use:
2001-11-01
International Classes:
007 - Primary Class
Class Status:
ACTIVE

OSHA's Inspections within Industry

Inspection Summary

Date:
2010-07-12
Type:
Referral
Address:
1860 SMITHTOWN AVENUE, RONKONKOMA, NY, 11779
Safety Health:
Safety
Scope:
Partial
Inspection Link:
View Inspection data on OSHA website

Inspection Summary

Date:
1992-09-03
Type:
FollowUp
Address:
1881 LAKELAND AVE., RONKONKOMA, NY, 11779
Safety Health:
Safety
Scope:
Partial
Inspection Link:
View Inspection data on OSHA website

Inspection Summary

Date:
1992-01-17
Type:
Planned
Address:
1881 LAKELAND AVE., RONKONKOMA, NY, 11779
Safety Health:
Safety
Scope:
Complete
Inspection Link:
View Inspection data on OSHA website

Inspection Summary

Date:
1986-09-30
Type:
Planned
Address:
160B WEST INDUSTRY COURT, DEER PARK, NY, 11729
Safety Health:
Safety
Scope:
Complete
Inspection Link:
View Inspection data on OSHA website

Paycheck Protection Program

Jobs Reported:
172
Initial Approval Amount:
$2,415,970
Date Approved:
2020-04-16
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Current Approval Amount:
$2,415,970
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
$2,443,418.1
Servicing Lender:
HSBC Bank USA, National Association
Use of Proceeds:
Payroll: $2,415,970

Court Cases

Court Case Summary

Filing Date:
2019-11-15
Status:
Terminated
Nature Of Judgment:
no monetary award
Jury Demand:
Plaintiff demands jury
Nature Of Suit:
Patent

Parties

Party Name:
CVD EQUIPMENT CORPORATION
Party Role:
Defendant
Party Name:
O2CURE LTD.
Party Role:
Plaintiff

Court Case Summary

Filing Date:
2010-01-26
Status:
Terminated
Nature Of Judgment:
no monetary award
Jury Demand:
Both plaintiff and defendant demand jury
Nature Of Suit:
Other Contract Actions

Parties

Party Name:
CVD EQUIPMENT CORPORATION
Party Role:
Plaintiff
Party Name:
TAIWAN GLASS INDUSTRIAL,
Party Role:
Defendant

Court Case Summary

Filing Date:
2009-03-16
Status:
Terminated
Nature Of Judgment:
Missing
Jury Demand:
Neither plaintiff nor defendant demands jury
Nature Of Suit:
Other Contract Actions

Parties

Party Name:
CVD EQUIPMENT CORPORATION
Party Role:
Plaintiff
Party Name:
AKZO NOBEL POLYMER CHEMICALS L
Party Role:
Defendant

Reviews Leave a review

This company hasn't received any reviews.

Related by officers

RICHARD CATALANO

RICKY'S TANKS TOPS TEES RICK C. ENTERTAINMENT, INC. ALBANY R.C. ENTERPRISES INC. RER PROPERTIES, INC. TLC IRRIGATION INC

EMMANUEL LAKIOS

LIGHTHOUSE TECH DEVELOPMENT CORP.

Related by address

355 SOUTH TECHNOLOGY DRIVE, CENTRAL ISLIP, NY, United States, 11722

555 N RESEARCH CORPORATION CVD MATERIALS CORPORATION CVD MESOSCRIBE TECHNOLOGIES CORPORATION FLA SALES, INC.

Date of last update: 17 Mar 2025

Sources: New York Secretary of State

Privacy policy Policy
About us About us
Contacts Contact us

© 2025 bizyork.com, Part of Big Data Integrated